SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ARAY Accuray Cyberknife Robotic RadioSurgery
ARAY 1.445-2.4%Oct 29 3:59 PM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Savant7/31/2012 12:20:45 PM
   of 94
 
Accuray Incorporated to Report Financial Results for Fourth Quarter and Fiscal
Year 2012

SUNNYVALE, Calif., July 31, 2012 /PRNewswire via COMTEX/ -- Accuray Incorporated
(ARAY), the premier radiation oncology company, today announced that it will
report results for its fourth quarter and fiscal year 2012, ended June 30, 2012
on Thursday, September 6, 2012 after the market closes.

A conference call to review the results will begin at 2:00 p.m. PDT/5:00 p.m. EDT
and will be hosted by Euan S. Thomson, Ph.D., president and chief executive
officer and Derek Bertocci, senior vice president and chief financial officer.

The conference call dial-in numbers are 1-800-295-4740 (USA) or 1-617-614-3925
(International), Conference ID: 89497327. In addition, a dial-up replay of the
conference call will be available beginning September 6, 2012 at 5:00 p.m.
PDT/8:00 p.m. EDT and ending on September 13, 2012. The replay telephone number
is 1-888-286-8010 (USA) or 1-617-801-6888 (International), Conference ID:
79000863.

A live webcast of the call will also be available from the Investor Relations
section of the corporate website at accuray.com. A webcast
replay can be accessed on the corporate website beginning Thursday, September 6,
2012 at approximately 5:00 p.m. PDT/8:00 p.m. EDT. The replay will remain
available until Accuray announces its results for the first quarter of fiscal
2013, ending September 30, 2012.

About Accuray

Accuray Incorporated (ARAY), based in Sunnyvale, Calif., is the premier radiation
oncology company that develops, manufactures and sells personalized innovative
treatment solutions that set the standard of care, with the aim of helping
patients live longer, better lives. The Company's leading edge technologies - the
CyberKnife and TomoTherapy Systems - are designed to deliver radiosurgery,
stereotactic body radiation therapy, intensity modulated radiation therapy, image
guided radiation therapy, and adaptive radiation therapy. To date, more than 635
systems have been installed in leading hospitals around the world. For more
information, please visit accuray.com.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext